Mureva is the first FDA-authorized device for radiation-induced oral mucositis. Its standardized 10-minute daily PBM treatment is designed to fit within the radiation therapy workflow.
Thank you for visiting us at ASTRO 2026
Continue exploring Mureva
Reduces Severe OM | Protects Patient Function | Simplifies PBM Delivery
54%
RELATIVE REDUCTION IN SEVERE ORAL MUCOSITIS
(p=0.016)
Severe oral mucositis through two weeks post-IMRT in FDA-indicated subgroup: 37% with Mureva vs 81% with sham, n=40
MUREVA PIVOTAL TRIAL PRESENTATION
Dr. Pratish Shah, MD, MBA | Tuesday, September 29 | 12:30–12:35 p.m. ET | Room 109
Thank you for visiting us at ASTRO 2026
Continue exploring Mureva
Reduces Severe OM | Protects Patient Function | Simplifies PBM Delivery
Mureva is the first FDA-authorized device for radiation-induced oral mucositis. Its standardized 10-minute daily PBM treatment is designed to fit within the radiation therapy workflow.
PIVOTAL TRIAL PRESENTATION
Pratish Shah, MD, MBA | Tuesday, September 29 | 12:30–12:35 p.m. ET | Room 109
54%
RELATIVE REDUCTION IN SEVERE ORAL MUCOSITIS
(p=0.016)
Severe oral mucositis through two weeks post-IMRT in FDA-indicated subgroup: 37% with Mureva vs 81% with sham, n=40